000044592 000__ 02529cam\a22003735i\4500
000044592 001__ 44592
000044592 003__ SzGeWIPO
000044592 005__ 20230203124839.0
000044592 006__ m\\\\eo\\d\\\\\\\\
000044592 007__ cr bn |||m|||a
000044592 008__ 211202s2021\\\\enk\\\\\o\\\\\\00\0\eng\d
000044592 020__ $$a9781788978200$$qelectronic book
000044592 035__ $$aeep9781788978200
000044592 035__ $$a(OCoLC)1269509636
000044592 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000044592 041__ $$aeng
000044592 08204 $$a344.240416
000044592 1001_ $$aKohli, Vishv P.
000044592 24510 $$aCounterfeit and Falsified Medicines in the EU :$$bA Legal Perspective.
000044592 264_1 $$a[Northampton, England] :$$bEdward Elgar Publishing Ltd.,$$c2021.
000044592 300__ $$a192 pages.
000044592 336__ $$atext$$2rdacontent
000044592 337__ $$acomputer$$2rdamedia
000044592 338__ $$aonline resource$$bcr$$2rdacarrier
000044592 4901_ $$aElgar Studies in Health and the Law Ser.
000044592 5050_ $$aPreface -- 1. Introduction to counterfeit and falsified medicines -- 2. Counterfeit and falsified medicines – case studies -- 3. Medicines law – an analysis of the Falsified Medicines Directive -- 4. IP law – an analysis of the Enforcement Directive and the Customs Regulation -- 5. Criminal law and counterfeit and falsified medicines -- 6. Conclusion and recommendations -- Index
000044592 520__ $$aThis timely book investigates the issue of counterfeit and falsified medicines (CFM) in the EU, identifying that this is a problem that lies at the intersection of three spheres of law – medicine, intellectual property (IP), and criminal law. The book highlights key issues such as infiltration of the legal supply chain and the involvement of organised crime, analysing relevant EU law and demonstrating the challenges of CFM.  Using examples from several case studies, Vishv Priya Kohli reveals the gaps in the current legal framework, underlining the particular difficulties created by the interplay between different areas of law as well as the lack of criminal penalties. The author explores areas where improvements have already been made, in particular through the Falsified Medicines Directive, and articulates a number of recommendations to fill in the gaps, for example by harmonizing criminal law and building synergies within law enforcement.  Counterfeit and Falsified Medicines in the EU will be of great interest to academics and students in IP, health and medical law, and criminal law in the EU. It will also prove valuable for practitioners and policymakers working in and with enforcement authorities in the EU, as well as those working in the medical field itself.
000044592 650_0 $$aIntellectual Property Law.
000044592 650_0 $$aMedical Law.
000044592 650_0 $$aCriminal Law.
000044592 655_0 $$aElectronic books.
000044592 830_0 $$aElgar Intellectual Property and Global Development series.
000044592 85641 $$uhttps://www.elgaronline.com/display/9781788978194.xml$$yView eBook
000044592 904__ $$aBook
000044592 942__ $$cEBOOK
000044592 980__ $$aOS